Rhenman & Partners Asset Management Ab Procept Bio Robotics Corp Transaction History
Rhenman & Partners Asset Management Ab
- $840 Million
- Q1 2025
A detailed history of Rhenman & Partners Asset Management Ab transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 448,000 shares of PRCT stock, worth $27.1 Million. This represents 3.11% of its overall portfolio holdings.
Number of Shares
448,000
Previous 420,345
6.58%
Holding current value
$27.1 Million
Previous $33.8 Million
22.89%
% of portfolio
3.11%
Previous 3.53%
Shares
8 transactions
Others Institutions Holding PRCT
# of Institutions
301Shares Held
41.9MCall Options Held
293KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.13MShares$310 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$211 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.14MShares$129 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.42MShares$85.5 Million0.05% of portfolio
-
State Street Corp Boston, MA1.19MShares$71.7 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.69B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...